Raising $175M to Translate Nature Into Medicine with Viswa Colluru
The Deep End by ODF
The Biotech Funding Model
The traditional model historically has been to sell the thesis and technology or ultimately sell assets that are pretty early in clinical development to large pharma. In order to basically be a part of this biotech movement you know needed to have had a lot of experience under your belt done this before. Today for the tech bio I would say there's a wide spectrum of water seed and a series a looks like but what you really need to align with your investors on is what kind of company are you going to end up being?
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
